Figure 1.

Study design. Patients with advanced solid tumors underwent tumor needle biopsy before and after 10–14 days of treatment with a protein kinase inhibitor, administered as standard treatment for their advanced disease or, off-label, prior to standard palliative chemotherapy. LC-MS/MS; liquid chromatography coupled to tandem mass spectrometry.